Original language | English (US) |
---|---|
Pages (from-to) | 1916-1918 |
Number of pages | 3 |
Journal | Rheumatology (United Kingdom) |
Volume | 55 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2016 |
Funding
This work was supported by the National Institutes of Health [K23 AR059763, R21 AR068035 to M.H.); and the Scleroderma Research Foundation to M.H. Novartis funded the clinical trial but was not involved in the preparation of this correspondence. No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript.
ASJC Scopus subject areas
- Pharmacology (medical)
- Rheumatology